Table 1.
Sex (M/F) | 8/12 |
Age at disease onset (mean years +SD) | 34 ± 10 |
Follow-up duration (years) | 7.69 ± 8.5 (1-18) |
Uveitis | 7/20 (35%) |
Aphtosis | 6/20 (30%) |
Articular symptoms | 4/20 (20%) |
NeuroBehçet | 3/20(15%) |
Treatments | Colchicine, methylprednisolon, cyclophosphamid |